In preclinical models, HIF2, the transcription factor formed by HIF2α and an aryl hydrocarbon receptor nuclear translocator (ARNT) protein, and not the canonical HIF family member HIF1α, drives ccRCC proliferation in vitro and in vivo5,6. Here, ARNT is linked to nonpapillary renal cell carcinoma.